Can Losartan and Paxlovid Be Taken Together?
Yes, losartan can be safely co-administered with Paxlovid (nirmatrelvir/ritonavir) without dose adjustment or interruption. Losartan does not have clinically significant drug-drug interactions with the ritonavir component of Paxlovid.
Understanding the Drug Interaction Risk
The primary concern with Paxlovid is the ritonavir component, which acts as a strong CYP3A4 inhibitor 1. The FDA label explicitly warns about potentially severe, life-threatening, or fatal drug interactions with medications metabolized through this pathway 2. However, losartan's metabolism does not create a problematic interaction:
- Losartan is primarily metabolized by CYP2C9, not CYP3A4
- While ritonavir does inhibit CYP3A4, CYP2D6, and P-glycoprotein 3, these pathways are not the primary routes for losartan metabolism
- Losartan does not appear on lists of contraindicated or problematic medications requiring dose adjustment with Paxlovid
Clinical Management Algorithm
For patients currently taking losartan who need Paxlovid:
- Continue losartan at the current dose - no adjustment needed
- Initiate Paxlovid as indicated: 300 mg nirmatrelvir with 100 mg ritonavir twice daily for 5 days 2, 4
- Monitor blood pressure routinely, as you would normally
- No interruption of losartan is required during the 5-day Paxlovid course
Important Caveats for Other Medications
While losartan is safe, the broader context matters. Guidelines emphasize that prior to prescribing Paxlovid, you must review ALL medications the patient takes 2. Among commonly prescribed drugs:
- 56% have no interaction with Paxlovid
- 30% have potential interactions requiring management
- 14% require specific evaluation 5
High-risk medication classes that DO require intervention include:
- Statins (especially atorvastatin - requires dose reduction) 6
- Immunosuppressants like tacrolimus (requires interruption and close monitoring) 7
- Certain antiarrhythmics, sedatives, and anticoagulants 8, 9
Practical Considerations
The Liverpool COVID-19 Drug Interaction Tool is specifically recommended by WHO guidelines as an open repository for checking interactions 1. Use this resource when prescribing Paxlovid to any patient on multiple medications.
Renal function matters for Paxlovid dosing (though not specifically for the losartan interaction):
- Normal/mild impairment (eGFR ≥60): standard dose
- Moderate impairment (eGFR 30-59): reduce to 150 mg nirmatrelvir with 100 mg ritonavir twice daily 2, 4
- Severe impairment (eGFR <30): Paxlovid not recommended 2
The evidence strongly supports Paxlovid's effectiveness in reducing hospitalization by 39% and death by 61% in real-world settings 10, making it critical to prescribe when indicated - and the absence of interaction with losartan removes one barrier to its use in hypertensive patients with COVID-19.